Factors associated with discontinuation of antiretroviral therapy in HIV-infected patients with alcohol problems

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 19, Issue 8, 2007, Pages 1039-1047

  Kim, T W ^a   Palepu, A ^b   Cheng, D M ^a,c   Libman, H ^d   Saitz, R ^a,e   Samet, J H ^a,f  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e Youth Alcohol Prevention Center   (United States)

^f BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; COCAINE; DIAMORPHINE; VIRUS RNA;

ADULT; ALCOHOLISM; ARTICLE; BIVARIATE ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEPRESSION; DRUG WITHDRAWAL; ETHNICITY; FEMALE; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SUBSTANCE ABUSE;

EID: 34548622485     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120701294245     Document Type: Article

References (47)

1. Ahdieh, G.L., Silverberg, M.J., Palacio, H., Minkoff, H., Anastos, K., Young, M.A., et al. (2001). Discontinuation of potent antiretroviral therapy: Predictive value of, and impact on, CD4 cell counts and HIV RNA levels. AIDS, 15, 2101-2108.
2. Ahdieh, G.L., Tarwater, P.M., Schneider, M.F., Anastos, K., Cohen, M., Khalsa, A., et al. (2005). Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study. Journal of Acquired Immune Deficiency Syndromes, 38, 500-503.
3. Asch, S.M., Kilbourne, A.M., Gifford, A.L., Burnam, M.A., Turner, B., Shapiro, M.F., et al. (2003). Underdiagnosis of depression in HIV: Who are we missing? Journal of General Internal Medicine, 18, 450-460.
4. Bing, E.G., Burnam, M.A., Longshore, D., Fleishman, J.A., Sherbourne, C.D., London, A.S., et al. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the US. Archives of General Psychiatry, 58, 721-728.
5. Brady, K.T., & Sinha, R. (2005). Co-occurring mental and substance use disorders: The neurobiological effects of chronic stress. American Journal of Psychiatry, 162, 1483-1493.
6. Braithwaite, R.S., McGinnis, K.A., Conigliaro, J., Maisto, S.A., Crystal, S., Day, N., et al. (2005). A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcoholism: Clinical and Experimental Research, 29, 1190-1197.
7. Buchsbaum, D.G., Buchanan, R.G., Centor, R.M., Schnoll, S.H., & Lawton, M.J. (1991). Screening for alcohol abuse using CAGE scores and likelihood ratios. Annals of Internal Medicine, 115, 774-777.
8. Chen, R.Y., Westfall, A.O., Mugavero, M.J., Cloud, G.A., Raper, J.L., Chatham, A.G., et al. (2003). Duration of highly active antiretroviral therapy regimens. Clinical Infectious Disease, 37, 714-722.
9. Compton, W.M., Cottler, L.B., Jacobs, J.L., Ben-Abdallah, A., & Spitznagel, E.L. (2003). The role of psychiatric disorders in predicting drug dependence treatment outcomes. American Journal Psychiatry, 160, 890-895.
10. Conigliaro, J., Gordon, A.J., McGinnis, K.A., Rabeneck, L., & Justice, A.C. (2003). How harmful is hazardous alcohol use and abuse in HIV infection: Do healthcare providers know who is at risk? Journal of Acquired Immune Deficiency Syndromes, 33, 521-525.
11. Conway, K.P., Compton, W., Stinson, F.S., & Grant, B.F. (2006). Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on alcohol and related conditions. Journal of Clinical Psychiatry, 67, 247-257.
12. Cook, J.A., Grey, D., Burke, J., Cohen, M.H., Gurtman, A.C., Richardson, J.L., et al. (2004). Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. American Journal of Public Health, 94, 1133-1140.
13. Cook, J.A., Grey, D., Burke-Miller, J., Cohen, M.H., Anastos, K., Ghandi, M., et al. (2006). Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women. AIDS Care, 18, 93-100.
14. D'Arminio, M.A., Cozzi-Lepri, A., Phillips, A., De, L.A., Murri, R., Mussini, C., et al. (2005). Interruption of highly active antiretroviral therapy in HIV clinical practice: Results from the Italian cohort of antiretroviral-naive patients. Journal of Acquired Immune Deficiency Syndromes, 38, 407-416.
15. Fairfield, K.M., Libman, H., Davis, R.B., Eisenberg, D., Beckett, A., & Phillips, R.S. (2001). Brief communication. Detecting depression: Providing high quality primary care for HIV-infected patients. American Journal of Medical Quality, 16, 71-74.
16. Galvan, F.H., Bing, E.G., Fleishman, J.A., London, A.S., Caetano, R., Burnam, M.A., et al. (2002). The prevalence of alcohol consumption and heavy drinking among people with HIV in the US: Results from the HIV Cost and Services Utilization Study. Journal of Studies on Alcohol, 63, 179-186.
17. Galvan, F.H., Burnam, M.A., & Bing, E.G. (2003). Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people. Journal of Psychoactive Drugs, 35(Suppl. 1), S153-S160.
18. Golub, E.T., Latka, M., Hagan, H., Havens, J.R., Hudson, S.M., Kapadia, F., et al. (2004). Screening for depressive symptoms among HCV-infected injection drug users: Examination of the utility of the CES-D and the Beck Depression Inventory. Journal of Urban Health, 81, 278-290.
19. Grant, B.F., Stinson, F.S., Dawson, D.A., Chou, S.P., Dufour, M.C., Compton, W., et al. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on alcohol and related conditions. Archives of General Psychiatry, 61, 807-816.
20. Hasin, D.S., & Grant, B.F. (2002). Major depression in 6,050 former drinkers: Association with past alcohol dependence. Archives of General Psychiatry, 59, 794-800.
21. Hays, R.D., Cunningham, W.E., Sherbourne, C.D., Wilson, I.B., Wu, A.W., Cleary, P., et al. (2000). Health-related quality of life in patients with human immunodeficiency virus infection in the US: Results from the HIV Cost and Services Utilization Study. American Journal of Medicine, 108, 714-722.
22. Heath, K.V., Singer, J., O'Shaughnessy, M.V., Montaner, J.S., & Hogg, R.S. (2002). Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 31, 211.
23. Hogg, R.S., Heath, K., Bangsberg, D., Yip, B., Press, N., O'Shaughnessy, M.V., et al. (2002). Intermittent use of triple-combination therapy is predictive of mortality at baseline and after one year of follow-up. AIDS, 16, 1051-1058.
24. Ickovics, J.R., Hamburger, M.E., Vlahov, D., Schoenbaum, E.E., Schuman, P., Boland, R.J., et al. (2001). Mortality, CD4 cell count decline and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. Journal of American Medical Association, 285, 1466-1474.
25. Justice, A.C., Holmes, W., Gifford, A.L., Rabeneck, L., Zackin, R., Sinclair, G., et al. (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, 54(Suppl. 1), S77-S90.
26. Kerr, T., Marshall, A., Walsh, J., Palepu, A., Tyndall, M., Montaner, J., et al. (2005). Determinants of HAART discontinuation among injection drug users. AIDS Care, 17, 539-549.
27. Kerr, T., Palepu, A., Barness, G., Walsh, J., Hogg, R., Montaner, J., et al. (2004). Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Antiviral Therapy, 9, 407-414.
28. Kertesz, S.G., Larson, M.J., Horton, N.J., Winter, M., Saitz, R., & Samet, J.H. (2005). Homeless chronicity and health-related quality of life trajectories among adults with addictions. Medical Care, 43, 574-585.
29. Kessler, R.C., Andrews, G., Mroczek, D., Ustun, B., & Wittchen, H.U. (1998). The World Health Organization composite international diagnostic interview short form (CIDI-SF). Internal Journal of Methods in Psychiatric Research, 7, 171-185.
30. Kilbourne, A.M., Justice, A.C., Rollman, B.L., McGinnis, K.A., Rabeneck, L., Weissman, S., et al. (2002). Clinical importance of HIV and depressive symptoms among veterans with HIV infection. Journal of General Internal Medicine, 17, 512-520.
31. Li, X., Margolick, J.B., Conover, C.S., Badri, S., Riddler, S.A., Witt, M.D., et al. (2005). Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. Journal of Acquired Immune Deficiency Syndromes, 38, 320-328.
32. Lucas, G.M., Griswold, M., Gebo, K.A., Keruly, J., Chaisson, R.E., & Moore, R.D. (2006). Illicit drug use and HIV-1 disease progression: A longitudinal study in the era of highly active antiretroviral therapy. American Journal of Epidemiology, 163, 412-420.
33. McLellan, A.T., Lewis, D.C., O'Brien, C.P., & Kleber, H.D. (2000). Drug dependence, a chronic medical illness: Implications for treatment, insurance and outcomes evaluation. Journal of American Medical Association, 284, 1689-1695.
34. Miguez, M.J., Shor-Posner, G., Morales, G., Rodriguez, A., & Burbano, X. (2003). HIV treatment in drug abusers: Impact of alcohol use. Addiction Biology, 8, 33-37.
35. Mocroft, A., Phillips, A.N., Soriano, V., Rockstroh, J., Blaxhult, A., Katlama, C., et al. (2005). Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: Increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C co-infection. AIDS Research and Human Retroviruses, 21, 527-536.
36. Moss, A.R., Hahn, J.A., Perry, S., Charlebois, E.D., Guzman, D., Clark, R.A., et al. (2004). Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective study. Clinical Infectious Disease, 39, 1190-1198.
37. Radloff, L. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
38. Riley, E.D., Bangsberg, D.R., Guzman, D., Perry, S., & Moss, A.R. (2005). Antiretroviral therapy, hepatitis C virus and AIDS mortality among San Francisco's homeless and marginally housed. Journal of Acquired Immune Deficiency Syndromes, 38, 191-195.
39. Robins, L.N., Wing, J., Wittchen, H.U., Helzer, J.E., Babor, T.F., Burke, J., et al. (1988). The Composite International Diagnostic Interview: An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry, 45, 1069-1077.
40. Samet, J.H., Horton, N.J., Meli, S., Freedberg, K.A., & Palepu, A. (2004). Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcoholism: Clinical and Experimental Research, 28, 572-577.
41. Samet, J.H., Horton, N.J., Traphagen, E.T., Lyon, S.M., & Freedberg, K.A. (2003). Alcohol consumption and HIV disease progression: Are they related? Alcoholism: Clinical and Experimental Research, 27, 862-867.
42. Samet, J.H., Libman, H., Labelle, C., Steger, K., Lewis, R., Craven, D.E., et al. (1995). A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus. Archives of Internal Medicine, 155, 1629-1633.
43. Samet, J.H., Phillips, S.J., Horton, N.J., Traphagen, E.T., & Freedberg, K.A. (2004). Detecting alcohol problems in HIV-infected patients: Use of the CAGE questionnaire. AIDS Research and Human Retroviruses, 20, 151-155.
44. Smith, K.L., Horton, N.J., Saitz, R., & Samet, J.H. (2006). The use of the mini-mental state examination in recruitment for substance abuse research studies. Drug and Alcohol Dependence, 82, 231-237.
45. Sobell, L.C., & Sobell, M.B. (1992). Timeline follow-back: a technique for assessing self-reported alcohol consumption. In R.Z. Litten, & J.P. Allen (Eds.), Measuring Alcohol Consumption: Psychosocial and Biochemical Methods (pp. 41-69). Totowa, NJ: Humana Press, Inc.
46. Yuan, Y., L'italien, G., Mukherjee, J., & Iloeje, U.H. (2006). Determinants of discontinuation of initial highly active anti-retroviral therapy regimens in a US HIV-infected patient cohort. HIV Medicine, 7, 156-162.
47. Zeger, S.L., Liang, K.Y., & Albert, P.S. (1988). Models for longitudinal data: A generalised estimating equation approach. Biometrics, 44, 1049-1060.